If Keytruda® is not subsidised, the estimated cost is A$150,000 per patient for each year of treatment. Retail cost
If Keytruda® is not subsidised, the estimated cost is A$150,000...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $436.3M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.5¢ | 29.5¢ | $216.1K | 719.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 216921 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 249676 | 27 |
View Market Depth
| Last trade - 12.10pm 21/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |